121 related articles for article (PubMed ID: 36038484)
21. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
[TBL] [Abstract][Full Text] [Related]
22. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH; Tree AC; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Chan A; Dayes IS; Henderson D; Brown S; Cruickshank C; Burnett S; Duffton A; Griffin C; Hinder V; Morrison K; Naismith O; Hall E; van As N;
Lancet Oncol; 2019 Nov; 20(11):1531-1543. PubMed ID: 31540791
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.
Bergius S; Torvinen S; Muhonen T; Roine RP; Sintonen H; Taari K
Scand J Urol; 2017 Feb; 51(1):13-19. PubMed ID: 27809631
[TBL] [Abstract][Full Text] [Related]
25. Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes.
Berlin A; Cho E; Kong V; Howell KJ; Lao B; Craig T; Bayley A; Chung P; Gospodarowicz M; Warde P; Catton C; Bristow RG; Ménard C
Pract Radiat Oncol; 2015; 5(5):e473-e482. PubMed ID: 25899220
[TBL] [Abstract][Full Text] [Related]
26. Potency preservation following stereotactic body radiation therapy for prostate cancer.
Obayomi-Davies O; Chen LN; Bhagat A; Wright HC; Uhm S; Kim JS; Yung TM; Lei S; Batipps GP; Pahira J; McGeagh KG; Collins BT; Kowalczyk K; Bandi G; Kumar D; Suy S; Dritschilo A; Lynch JH; Collins SP
Radiat Oncol; 2013 Nov; 8():256. PubMed ID: 24180317
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.
Yeoh EE; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J; Weerasinghe S; Abeysinghe P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1072-83. PubMed ID: 16965866
[TBL] [Abstract][Full Text] [Related]
29. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer.
Lee WR; McQuellon RP; Harris-Henderson K; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):77-81. PubMed ID: 10656376
[TBL] [Abstract][Full Text] [Related]
30. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
[TBL] [Abstract][Full Text] [Related]
31. High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation.
Hjälm-Eriksson M; Ullén A; Nilsson S; Johansson H; Nilsson J; Castellanos E; Brandberg Y
Acta Oncol; 2022 Oct; 61(10):1179-1185. PubMed ID: 36062835
[TBL] [Abstract][Full Text] [Related]
32. Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.
Pinkawa M; Piroth MD; Fischedick K; Holy R; Klotz J; Nussen S; Krenkel B; Eble MJ
Strahlenther Onkol; 2009 Nov; 185(11):724-30. PubMed ID: 19899005
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life of head and neck cancer patients with successful oncological treatment.
Loimu V; Mäkitie AA; Bäck LJ; Sintonen H; Räsänen P; Roine R; Saarilahti K
Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2415-23. PubMed ID: 24986429
[TBL] [Abstract][Full Text] [Related]
34. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Dearnaley D; Syndikus I; Sumo G; Bidmead M; Bloomfield D; Clark C; Gao A; Hassan S; Horwich A; Huddart R; Khoo V; Kirkbride P; Mayles H; Mayles P; Naismith O; Parker C; Patterson H; Russell M; Scrase C; South C; Staffurth J; Hall E
Lancet Oncol; 2012 Jan; 13(1):43-54. PubMed ID: 22169269
[TBL] [Abstract][Full Text] [Related]
35. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.
Eisemann N; Nolte S; Schnoor M; Katalinic A; Rohde V; Waldmann A
BMC Urol; 2015 Apr; 15():28. PubMed ID: 25885890
[TBL] [Abstract][Full Text] [Related]
36. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
[TBL] [Abstract][Full Text] [Related]
37. Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD.
Mazur W; Kupiainen H; Pitkäniemi J; Kilpeläinen M; Sintonen H; Lindqvist A; Kinnula VL; Laitinen T
Health Qual Life Outcomes; 2011 Jan; 9():4. PubMed ID: 21235818
[TBL] [Abstract][Full Text] [Related]
38. Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
Lee WR; Dignam JJ; Amin MB; Bruner DW; Low D; Swanson GP; Shah AB; D'Souza DP; Michalski JM; Dayes IS; Seaward SA; Hall WA; Nguyen PL; Pisansky TM; Faria SL; Chen Y; Koontz BF; Paulus R; Sandler HM
J Clin Oncol; 2016 Jul; 34(20):2325-32. PubMed ID: 27044935
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life among patients with primary sclerosing cholangitis.
Haapamäki J; Tenca A; Sintonen H; Barner-Rasmussen N; Färkkilä MA
Liver Int; 2015 Sep; 35(9):2194-201. PubMed ID: 25546575
[TBL] [Abstract][Full Text] [Related]
40. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
